What is the prevalence of Severe combined immunodeficiency?

Severe combined immunodeficiency (SCID) is a rare and life-threatening group of genetic disorders characterized by the near-total absence of functional T-cell immunity. Current estimates suggest an incidence of approximately 1 in 50,000 to 1 in 100,000 live births, though the true prevalence is difficult to capture due to historical underdiagnosis and the rapid implementation of newborn screening programs globally.

What is the global prevalence and incidence of Severe combined immunodeficiency?

The incidence of Severe combined immunodeficiency is estimated to be between 1 in 50,000 and 1 in 100,000 live births globally. Because Severe combined immunodeficiency is a medical emergency, accurate data collection has improved significantly in countries that have adopted mandatory newborn screening (NBS) for T-cell receptor excision circles (TRECs). In regions without universal screening, many infants with Severe combined immunodeficiency may succumb to infections before a formal diagnosis is ever reached, meaning reported figures likely underestimate the true burden of the disease.

Are there demographic differences in how Severe combined immunodeficiency presents?

The distribution of Severe combined immunodeficiency is heavily influenced by the underlying genetic cause. For instance, X-linked Severe combined immunodeficiency (the most common form, caused by mutations in the IL2RG gene) primarily affects males, who account for approximately 45-50% of all cases. Other forms, such as those caused by adenosine deaminase (ADA) deficiency, follow an autosomal recessive inheritance pattern and affect males and females equally. While Severe combined immunodeficiency is universally considered a pediatric-onset condition—typically manifesting within the first few months of life—the introduction of newborn screening has allowed for earlier identification, often before the onset of severe, life-threatening infections.

Why is accurate data for Severe combined immunodeficiency challenging to obtain?

Calculating the exact prevalence of Severe combined immunodeficiency is complex due to several factors:

• Underdiagnosis: In countries without newborn screening, infants may pass away from "failure to thrive" or severe pneumonia without the underlying immunodeficiency being identified.


• Genetic Heterogeneity: There are over 20 different genetic mutations associated with Severe combined immunodeficiency, leading to variations in clinical severity.


• Geographic Variability: Certain populations exhibit higher frequencies of specific variants due to founder effects or higher rates of consanguinity in specific geographic regions.


• Community Insights: At DiseaseMaps.org, 7 people with Severe combined immunodeficiency have joined our community. These real-world patient experiences provide invaluable insights into the diagnostic journey and the long-term outcomes for those living with this condition, often highlighting the gaps between clinical literature and lived experience.

Next steps

• Consult a specialist: If you suspect a family history of primary immunodeficiency, consult a clinical immunologist or a genetic counselor immediately.


• Newborn Screening: Verify with your local health department that your region includes TREC-based screening for Severe combined immunodeficiency for all newborns.


• Connect with others: Join the community at DiseaseMaps.org to share your experiences and learn from other families navigating this diagnosis.


• Stay informed: Follow updates from the Immune Deficiency Foundation (IDF) regarding new clinical trials and treatment advancements like gene therapy.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Severe Combined Immunodeficiency.


• Orphanet: Severe Combined Immunodeficiency (SCID) - ORPHA:802.


• Online Mendelian Inheritance in Man (OMIM): Severe Combined Immunodeficiency (SCID).


• Immune Deficiency Foundation (IDF): Understanding SCID and Newborn Screening Data.